Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FMR LLC | 18.00M | $989.0M | 14.80% | +752.1K | 2026-06-30 |
| Siren, L.L.C. | 9.58M | $526.0M | 7.87% | -1.25M | 2026-06-30 |
| BlackRock, Inc. | 9.49M | $522.0M | 7.81% | +2.02M | 2026-06-30 |
| SAMSARA BIOCAPITAL, LLC | 6.90M | $379.0M | 5.67% | -- | 2026-06-30 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 6.79M | $373.0M | 5.59% | +588.2K | 2026-06-30 |
| WELLINGTON MANAGEMENT GROUP LLP | 6.73M | $369.0M | 5.53% | +9.4K | 2026-06-30 |
| Orbis Allan Gray Ltd | 5.93M | $326.0M | 4.88% | +1.75M | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.77M | $262.0M | 3.92% | +876.5K | 2026-06-30 |
| STATE STREET CORP | 4.73M | $260.0M | 3.89% | +697.4K | 2026-06-30 |
| Redmile Group, LLC | 4.31M | $237.0M | 3.55% | -4.76M | 2026-06-30 |
